Article Details
Retrieved on: 2018-02-16 03:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Cliff Asness increased its stake in Halozyme Therapeutics Inc (HALO) by 381.08% based on its latest 2017Q3 regulatory filing with the SEC. <b>Aqr Capital</b> <b>Management</b> Llc bought 90,500 shares as the company's stock rose 2.38% with the market. The hedge fund run by Cliff Asness held 114,248 shares of ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here